Article
Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway.
Journal of neuroinflammation - 16 Jun 2020
Li Sichen, Shi Yuan, Liu Peixi, Song Yaying, Liu Yingjun, Ying Lingwen, Quan Kai, Yu Guo, Fan Zhiyuan, Zhu Wei
Abstract excerpt
BACKGROUND: The regulation of vascular smooth muscle cell (VSMC) phenotype plays an important role in intracranial aneurysm (IA) formation and progression. However, the underlying mechanism remains unclear. Metformin is a 5' AMP-activated protein kinase (AMPK) agonist that has a protective effect on vasculature. The present study investigated whether metformin modulates VSMC phenotype switching via the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
